SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (70)11/7/1996 4:46:00 AM
From: Udo W. Perkuhn   of 2742
 
I guessed they wouldn't be able to restate, but would be nice. As for the results for last year having "zero significance" I disagree. When gross sales drop there is something very wrong. The accountants were concerned if the company could continue operations. This is all very bad. Although I'm sure the law suit took its toll and the settlement will show the company as having substantial earnings it doesn't look good. The faster management can put forth a plan for growth the better. Trying to get listed on NASDAQ should be the least of their worries. Primary concern should be boosting sales and developing new products. If they can show a good plan for that the stock price will go up. Otherwise, they should just distribute the settlement as dividends and fold up.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext